Evidence map›Paper›PMID 35208649›Full record

ReviewMedicina (Kaunas, Lithuania)2022

HELLP Syndrome-Holistic Insight into Pathophysiology.

Aida Petca, Bianca Corina Miron, Irina Pacu, Mihai Cristian Dumitrașcu, Claudia Mehedințu, Florica Șandru, Răzvan-Cosmin Petca, Ioana Cristina Rotar

Registry-linked trialAbstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07209748 (The Significance of Soluble CD163 as a Novel Biomarker in the Early Detection and Severity Assessment of HELLP Syndrome), which is not on this map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07209748 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

The Significance of Soluble CD163 as a Novel Biomarker in the Early Detection and Severity Assessment of HELLP Syndrome

TypeobservationalSponsorAssiut UniversityRan2025 to 2027Enrolled70ConditionsHELLP Syndrome Complicating PregnancyArmssCD163 level
3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aida Petca"Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.ORCID 0000-0002-4890-0978
Bianca Corina Miron"Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Irina Pacu"Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Mihai Cristian Dumitrașcu"Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Claudia Mehedințu"Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Florica Șandru"Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Răzvan-Cosmin Petca"Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.ORCID 0000-0003-4496-1535
Ioana Cristina Rotar"Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.ORCID 0000-0002-7700-2384

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HELLP syndrome, also known as the syndrome of hemolysis, elevated liver enzymes, and low platelets, represents a severe pregnancy complication typically associated with hypertension. It is associated with increased risks of adverse complications for both mother and fetus. HELLP occurs in 0.2-0.8% of pregnancies, and, in 70-80% of cases, it coexists with preeclampsia (PE). Both of these conditions show a familial tendency. A woman with a history of HELLP pregnancy is at high risk for developing this entity in subsequent pregnancies. We cannot nominate a single worldwide genetic cause for the increased risk of HELLP. Combinations of multiple gene variants, each with a moderate risk, with concurrent maternal and environmental factors are thought to be the etiological mechanisms. This review highlights the significant role of understanding the underlying pathophysiological mechanism of HELLP syndrome. A better knowledge of the disease's course supports early detection, an accurate diagnosis, and proper management of this life-threatening condition.

Indexed as

HELLP SyndromeHypertensionPre-EclampsiaPregnancy ComplicationsFemaleHumansPregnancyDICgeneticHELLPmicroangiopathypathogenesisplacenta

Identifiers

PMID35208649
PMCPMC8875732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.